Cure pharmaceutical reports third quarter 2022 results with strong sequential and year over year revenue increases and continued high margins

New marketing programs showing encouraging early results sherman oaks, ca / accesswire / november 22, 2022 / cure pharmaceutical holding corp. (otcqb:curr) ("cure" or the "company"), a proprietary broad platform technology and wellness company, today announced results for the quarter ended september 30, 2022. key operational highlights included the following: revenue in the third quarter surged 32.1% year-over-year and 58.9% sequentially from q2 2022 to $1.8 million with further increases expected in q4.
CURR Ratings Summary
CURR Quant Ranking